Providers utilize business intelligence to monitor referral patterns and collaborate with clinicians who order their services. Such analytics tools have also been deployed in the specialty to improve productivity, track patient satisfaction and bolster quality.
Heated tension between state and federal AI regulators is coming, predict two attorneys subspecialized in AI startup success, data privacy and cybersecurity.
Shockwave Medical, now a part of Johnson & Johnson MedTech, sits at the top of the IVL market, but things are starting to get more competitive. Boston Scientific gained its own IVL system when it acquired Bolt Medical in 2025.
Can you guess the (lightly disputed) champion of healthcare AI suppliers? Here’s a hint. This company caters to physicians and just this week reached a valuation of $12B.
The drug Caplyta, owned by Intra-Cellular Therapies, is being used to treat bipolar disorder and schizophrenia. In 2024, it brought in more than $481 million in sales.
The companies argue that the U.S. Department of Justice has failed to adequately demonstrate how, and in which regions of the country, the merger would harm competition. They are asking a federal court to throw out the case.
The motion is being advanced by religious groups and hedge funds alike, with the decision to develop a report set to be voted on at the UnitedHealth Group 2025 annual meeting.
The new law will require private equity firms to make disclosures related to organizational structure and finances if they intend to operate a medical facility or provider organization in the state.
While artificial intelligence engineers and consultants took the top two spots, physical therapists and advanced practice providers also landed among the 25 fastest growing jobs in the U.S.